Colin Collins

Researcher
  • University of British Columbia
  • Vancouver Prostate Centre
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Prostate Cancer

    Targeting Tumour Plasticity in Advanced Prostate Cancer

    Nearly 20% of advanced prostate cancer patients relapse on potent androgen receptor (AR) targeted therapies with a highly aggressive disease called treatment induced neuroendocrine prostate cancer (NE...

    Read More
  • Prostate Cancer

    Targeting the adaptive molecular landscape in castrate-resistant prostate cancer

    TFRI’s Vancouver-based prostate cancer progression team is primed and ready to continue its world-class research on advanced, drug-resistant tumours after receiving a five-year renewal of Terry ...

    Read More
  • Completed
    Prostate Cancer

    Prostate cancer progression

    Significant progress has been made in treating prostate cancer, but survival rates remain low for the most advanced, drug-resistant forms of the disease – a reality the TFRI’s prostate can...

    Read More

Related News & Events

  • Research Highlight|October 16, 2019

    New finding sheds light on neuroendocrine prostate cancer progression

    New study reveals how RNA splicing of BHC80 promotes the development of treatment-induced neuroendocrine prostate cancer, providing potential avenue f...

  • Research Highlight|June 03, 2019

    New research suggests immunotherapy could help nearly 50 per cent of patients with rare mesothelioma

    A team of scientists partly funded by the Terry Fox Research Institute has shown that nearly half of all patients with peritoneal mesothelioma (PeM), ...

  • All News & Events